Cart
sales@molnova.com
Tyrphostin AG 112
CAS No. 144978-82-5
Tyrphostin AG 112( —— )
Catalog No. M22092 CAS No. 144978-82-5
Tyrphostin AG 112 is an inhibitor of EGFR phosphorylation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 37 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 122 | In Stock |
|
| 50MG | 179 | In Stock |
|
| 100MG | 267 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 647 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTyrphostin AG 112
-
NoteResearch use only, not for human use.
-
Brief DescriptionTyrphostin AG 112 is an inhibitor of EGFR phosphorylation.
-
DescriptionTyrphostin AG 112 is an inhibitor of EGFR phosphorylation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number144978-82-5
-
Formula Weight236.23
-
Molecular FormulaC13H8N4O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (529.15 mM)
-
SMILESNC(=C(/C#N)C#N)\C(C#N)=C\c1ccc(O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rodrigo Franco, et al. Epidermal Growth Factor Receptor Is Activated by Hyposmolarity and Is an Early Signal Modulating Osmolyte Efflux Pathways in Swiss 3T3 Fibroblasts. Pflugers Arch. 2004 Mar;447(6):830-9.
molnova catalog
related products
-
PD-161570
PD-161570 is a potent and ATP-competitive human FGF-1 receptor inhibitor with an IC50 of 39.9 nM and a Ki of 42 nM. PD-161570 also inhibits the PDGFR, EGFR and c-Src tyrosine kinases with IC50 values of 310 nM, 240 nM, and 44 nM, respectively.
-
Alflutinib methanesu...
Alflutinib methanesulfonate (AST-2818, ASK120067) is a third generation EGFR mutation selective tyrosine kinase inhibitor.
-
O-Desmethyl gefitini...
O-Desmethyl gefitinib inhibits EGFR (IC50: 36 nM in subcellular assays). In human plasma, O-Desmethyl gefitinib is an active metabolite of Gefitinib.
